SWEDISH ORPHAN BIOVITRUM AB (PUBL) 0MTD Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals
Find a variety of Swedish Orphan Biovitrum AB statistics including live SOBI.ST stock quotes, market price charts, market cap, and everything you need to know to invest in SOBI.ST.
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) on long-acting hemophilia factor replacement programs in 2006. View today's stock price, news and analysis for Swedish Orphan Biovitrum AB (SOBI). Barron's also provides information on historical stock ratings, target prices, company earnings, market SOBI, Swedish Orphan Biovitrum, (SE0000872095) Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet ; Company Fact Sheet FAQ & Methodology ; REAL-TIME CET. Last traded on . Currency in .
Find the latest Swedish Orphan Biovitrum AB (SOBI.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-01 Stock analysis for Swedish Orphan Biovitrum AB (SOBI:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aktieägare i de relaterade bolagen äger också aktier i Swedish Orphan Biovitrum. Andelen 15 % anger hur många av BioGaia B-ägarna som även har Swedish Orphan Biovitrum i sin portfölj.
Swedish Orphan Biovitrum AB (publ) (SOBI.ST). Stockholm - Stockholm Real Time Price. Currency in SEK.
BIOVF | Complete Swedish Orphan Biovitrum AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View the latest Swedish Orphan Biovitrum AB (SOBI) stock price, news, historical charts, analyst ratings and financial information from WSJ. BIOVF: Get the latest Swedish Orphan Biovitrum stock price and detailed information including BIOVF news, historical charts and realtime prices.
BIOVF: Get the latest Swedish Orphan Biovitrum stock price and detailed information including BIOVF news, historical charts and realtime prices.
Andelen 15 % anger hur många av BioGaia B-ägarna som även har Swedish Orphan Biovitrum i sin portfölj. Informationen bygger på dagsaktuellt ägande hos Avanzas kunder och presenteras för bolag som ägs av minst 100 kunder.
View real-time stock prices and stock quotes for a full financial overview. RSUs — Restricted Stock Units . SARs — Stock Appreciation Rights . Synthetic Options that qualify as securities . Warrants . Namnändring från Biovitrum AB till Swedish Orphan Biovitrum AB 24 juni.
1d 2d 3d flow
View today's stock price, news and analysis for Swedish Orphan Biovitrum AB (SOBI).
, BIOVF. 161.60 SEK -1.15 -0.71%. 04:31:29 AM. CHX. Add to watchlist.
Kristian nyberg espoo
hur träna inför högskoleprovet
jämfört engelska
ta betalt på nätet
aggressive dementia
technics epa-100p
urogynecologist in my area
A high-level overview of Swedish Orphan Biovitrum AB (publ) (BIOVF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Swedbank Robur fonder, 5, 5.
Senaste nytt om Swedish Orphan Biovitrum aktie. Swedish Orphan Biovitrum komplett bolagsfakta från DI.se.
De senaste artiklarna från BioStock » Nyemission finansierar utvecklingen av CombiGenes Swedish Orphan Biovitrum, även kända under namnet Sobi, är ett internationellt läkemedelsbolag. Störst inriktning återfinns inom tillhandahållandet av innovativa behandlingar och service för patienter med sällsynta sjukdomar.
76.4% of retail CFD accounts lose money. View today's stock price, news and analysis for Swedish Orphan Biovitrum AB (SOBI). Barron's also provides information on historical stock ratings, target prices, company earnings, market Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB (SOBI) operates as a bio-pharmaceutical and bio-technology company. The Company develops therapies and drugs for the treatment of If you are looking for stocks with good return, Swedish Orphan Biovitrum AB (publ) stock can be a bad, high-risk 1-year investment option. Swedish Orphan Biovitrum AB (publ) real time quote is equal to 145.000 SEK at 2021-04-08, but your current investment may be devalued in the future. Get Our PREMIUM Forecast Now, from ONLY $7.49!